These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 15948095)

  • 1. Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure.
    Gustafsson F; Steensgaard-Hansen F; Badskjaer J; Poulsen AH; Corell P; Hildebrandt P
    J Card Fail; 2005 Jun; 11(5 Suppl):S15-20. PubMed ID: 15948095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
    O'Donoghue M; Chen A; Baggish AL; Anwaruddin S; Krauser DG; Tung R; Januzzi JL
    J Card Fail; 2005 Jun; 11(5 Suppl):S9-14. PubMed ID: 15948094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid point-of-care NT-proBNP optimal cut-off point for heart failure diagnosis in primary care.
    Verdú JM; Comín-Colet J; Domingo M; Lupón J; Gómez M; Molina L; Casacuberta JM; Muñoz MA; Mena A; Bruguera-Cortada J
    Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):613-9. PubMed ID: 22541282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population.
    Groenning BA; Raymond I; Hildebrandt PR; Nilsson JC; Baumann M; Pedersen F
    Heart; 2004 Mar; 90(3):297-303. PubMed ID: 14966052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino-terminal pro-brain natriuretic peptid in prediction of left ventricular ejection fraction.
    Bajrić M; Baraković F; Kusljugić Z; Salkić N; Jahić E; Ascerić M; Ljuca F; Mrsić D; Smajić E; Caluk J; Hajrić R
    Bosn J Basic Med Sci; 2008 Aug; 8(3):282-6. PubMed ID: 18816264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].
    Wu YR; Chen SB; Huang MR; Zhang YQ; Sun K; Chen S
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):161-4. PubMed ID: 15833183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of brain natriuretic peptides in primary care patients with the clinical diagnosis of chronic heart failure.
    Zuber M; Cuculi F; Attenhofer Jost CH; Kipfer P; Buser P; Seifert B; Erne P
    Scand Cardiovasc J; 2009; 43(5):324-9. PubMed ID: 19247872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Terminal Prohormone of Brain Natriuretic Peptide (NT-proBNP) as a Diagnostic Biomarker of Left Ventricular Systolic Dysfunction in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).
    Andrijevic I; Milutinov S; Lozanov Crvenkovic Z; Matijasevic J; Andrijevic A; Kovacevic T; Bokan D; Zaric B
    Lung; 2018 Oct; 196(5):583-590. PubMed ID: 29951921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NT-ProBNP in outpatients after myocardial infarction: interaction between symptoms and left ventricular function and optimized cut-points.
    Luchner A; Hengstenberg C; Löwel H; Buchner S; Schunkert H; Riegger GA; Holmer S
    J Card Fail; 2005 Jun; 11(5 Suppl):S21-7. PubMed ID: 15948096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
    Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
    Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure.
    Fuat A; Murphy JJ; Hungin AP; Curry J; Mehrzad AA; Hetherington A; Johnston JI; Smellie WS; Duffy V; Cawley P
    Br J Gen Pract; 2006 May; 56(526):327-33. PubMed ID: 16638247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of renal failure on N-terminal Pro-Brain natriuretic peptide in patients admitted to emergency department with acute dyspnea.
    Çolak A; Çuhadar S; Gölcük B; Gölcük Y; Özdoğan Ö; Çoker I
    Anadolu Kardiyol Derg; 2014 Sep; 14(6):519-24. PubMed ID: 25233498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ability of NT-proBNP to detect chronic heart failure and predict all-cause mortality is higher in elderly Chinese coronary artery disease patients with chronic kidney disease.
    Fu S; Luo L; Ye P; Yi S; Liu Y; Zhu B; Wang L; Xiao T; Bai Y
    Clin Interv Aging; 2013; 8():409-17. PubMed ID: 23723693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the impact of different N terminal pro brain natriuretic peptide thresholds on echocardiography services.
    Yii E; Fersia O; McFadyen A; Isles C
    ESC Heart Fail; 2022 Feb; 9(1):627-635. PubMed ID: 34877791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.
    Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH
    J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction.
    Huang A; Qi X; Hou W; Qi Y; Zhao N; Liu K
    Acta Cardiol; 2018 Feb; 73(1):41-48. PubMed ID: 28944719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.